SQSTM1 and cancer: As our results showed that autophagy inhibitor, knockdown of Nrf2 or p62 significantly enhanced the anticancer effects of ESI, the data therefore highlight the therapeutic potential of ESI in combination with related pathway inhibitors in treatment of cancer.